Originally aired on March 14, 2019 on http://ctrnetwork.com In today’s program Dr. Anderson will discuss the uses of IV therapies in integrative cancer therapies. What is it? How does it work? Why would I need it? What has Dr. Anderson’s experience been with it? Why doesn’t my hospital offer this? Dr. Anderson was involved in …
Originally aired on February 21, 2019 on ctrnetwork.com In today’s program Dr. Anderson will look at the topics included in the third and fourth chapters of “Outside the Box Cancer Therapies”. Controversy surrounds oncology from all sides. In today’s program Dr. Anderson will use Chapters 3&4 from the book to talk about the similarities and …
Originally aired on February 14, 2019 on www.ctrnetwork.com In today’s program Dr. Anderson will look at the topics included in the first two chapters of “Outside the Box Cancer Therapies. Controversy surrounds oncology from all sides. What is (or can there be) “real hope” for a cancer patient? What is “false hope” and why do …
This appeared originally in the August-September issue of the Townsend Letter, 2018 It outlines the evolution of, a case series using and the actual protocols we now employ in our integrative metabolic cancer therapy.
Iron status and the administration of iron in patients who have cancer is a delicate balance. Too low and the patient often has significant comorbidity – too much and the cancer can progress. There are well thought out guidelines for the use of iron in patients with cancer and this presentation summarizes those guidelines as …
Iron Assessment and Treatment in Oncology Patients Read More »
QUESTION: My understanding has always been that serum C level remain elevated, ideally between 350 and 450 ng/dl for several hours. What I have found is that the mid treatment results of serum C as determined by the Tru-2-go glucometer (one hour into treatment after half of the solution has been infused) generally gets within …
Design: Four systematic review papers published in the past two years all take a different approach to describe our ever evolving and deepening understanding of the activity of Reductive-Oxidative balance (ReDox). These four papers (and many like them) have sought to update the scientific community in regard to our ever evolving understanding of this precariously …
The documentary film that myself, my colleague Akbar Kahn MD and others were interviewed in regarding LDN and cancer has been released. I am so happy this all came together! (If you don’t know what the medication “LDN” is the film explains it all). It can be downloaded from this site: "The Game Changer" – …
QUESTION: The case is more tricky just because of the little girl’s age. At 9 months of age she was diagnosed with AML subtype M7. Chemo was started right away and at the time my role was to support chemotherapy with homeopathy and treat the mother with supplementation as she is actively nursing. She made …
QUESTION: I follow your AMSA-BIORC HDIVC formulas. I was wondering if you ever add bicarbonate to the formulas? And if not, why not? Does it decrease the effectiveness of IVC? ANSWER: There are two reasons for Bicarb in oncology, pH and Anti-cancer potential. pH: I do add Bicarb in peripheral IV’s if the pH is …
QUESTION: In regard to the ketogenic diet, do you often recommend this for cancer patients? Are there particular types of cancer that you are more prone to recommend this for? How so? If someone is moving forward with chemo, would you still recommend this diet? ANSWER: Bottom line with ketogenic diet boils down to: 1. …
Dr. Anderson has been involved in integrative oncology for the past three decades. In 2009 he joined the Bastyr Integrative Oncology Research Center as Chief of IV services and began to put his years of experience into a formal cancer research program. During the years of that National Institutes of Health funded research he was …
Reference: The efficacy and safety of probiotics in people with cancer: a systematic review. Design: A systematic review was carried out to collect, analyze and synthesize all available data on the efficacy and safety of probiotics in people with cancer. Eleven studies (N = 1557 participants) were included for assessing efficacy. Seventeen studies (N = …
PROBIOTICS IN ONCOLOGY – BLOG AND LITERATURE REVIEW Read More »
QUESTION: Do you have any research/ case studies on using hbot in oncology? I’m having a tough time with understanding why it is being done, have you written about it and i missed it? It possibly makes sense after patient is given an iv but i have had requests from patients and seen orders for …
THE ROLE OF HYPERBARIC OXYGEN THERAPY IN ONCOLOGY CONT Read More »
QUESTION: Pt with follicular lymphoma referred over for IV therapy.. They recommended just nutrient and glutathione pushes but are open to other therapies. I see in my lecture notes a case where IVC, Viscum, and DCA were used. Is IVC alone a good start? Would love some guidance or to be pointed to appropriate references. ANSWER: …
QUESTION: 67yo M with Stage 4 Prostate CA with mets to spine. He is getting IVC50 and Artesunate 120mg 2x/week and Mistletoe injections at home. He did one round of firmagon (Degeralix) one year ago when he was diagnosed, then another dose around September, far less frequent than his oncologist advised. His PSA was not doing too …
IV AND HORMONAL SUPPORT IN STAGE IV PROSTATE CANCER CONT Read More »
QUESTION: Vitamin E and D get a lot of press and use in oncology therapy, but you don’t hear a lot about vitamin A. Do you think it has a role in cancer? If so, at what dosage? ANSWER: I ran across this regarding retinol and was thinking back a couple decades ago when we used it …
QUESTION: I’m stumped on a case and would appreciate your advice. Could you advise on what might be the most effective Chemotherapy Induced Peripheral Neuropathy (CIPN) therapies in this case? Neuropathy is limiting her chemo tx options and funds are moderately limited, so I’d like to hone in on the best possible tx promptly. Case: …
CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT OPTIONS CONT Read More »
QUESTION: I am working with an oncologist who is worried about me using glutathione and HDIVC in a shared cancer patient who is also getting sodium thiosulfate, to lessen the side effects (neuropathy) of cisplatin, because he says it is his understanding that there is significant concern about timing and use of anything that can …
SODIUM THIOSULFATE, ASCORBATE AND OTHER THIOLS CONT Read More »
QUESTION: I will be starting artesunate with a patient in the near future (hopefully in the next week). She has done HIVC with her chemo. However, the chemo has not worked well for the patient and she now is willing to entertain further treatments. I have read your artesunate summary for IV use and you mention …
QUESTION: Have you ever treated a patient with Alzheimer’s and cancer using high dose IVC? If so are there any caveats? ANSWER: With CA and Alzheimers you treat the same but it is an issue as they often do not like Tx, and forget why they are doing it. Aside from that and having a support …
QUESTION: Follow up PET scan for patient with a history of dendritic sacroma in subclavicular lymph node. The patient had one at 1 year and was clear? He’s asking me if he needs to go back to his oncologist and get another one, it has been 4 years. Patient is symptom free, healthy in his …
After doing this for a while I run through the following with a new patient case: All the details, Stage/Grade, Prior and concurrent Tx Patient goals (often we assume we are to Tx the cancer and find out that isn’t what they want.) So is it “aggressive cancer focused Tx” or mitigating damage from prior …
A seeming conundrum regarding the ability of some leukemic cells (i.e. CLL) to sequester ascorbate (ASC) has led to confusion regarding the safety and utility of high dose ascorbate delivered via IV (IVAA). This has led to some apparent confusion between this concern and the apparent positive benefits of IVAA seen in clinical practice. As …
LEUKEMIAS AND OXIDATIVE THERAPIES INCLUDING INTRAVENOUS ASCORBIC ACID Read More »
QUESTION: How often and for how long should I dose an oncology patient with IV Vitamin C? ANSWER: This answer is based on a retrospective analysis of our BIORC IV patients and those who responded to IVC. If it is a patient new to IVC or there has been a Tx break of any time …
IV VITAMIN C TREATMENT DURATION IN ONCOLOGY CONT Read More »
